JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M511104200 on March 3, 2006

J. Biol. Chem., Vol. 281, Issue 18, 12751-12759, May 5, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/18/12751    most recent
M511104200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miedel, M. T.
Right arrow Articles by Weisz, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miedel, M. T.
Right arrow Articles by Weisz, O. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Posttranslational Cleavage and Adaptor Protein Complex-dependent Trafficking of Mucolipin-1*

Mark T. Miedel{ddagger}, Kelly M. Weixel{ddagger}1, Jennifer R. Bruns{ddagger}, Linton M. Traub§, and Ora A. Weisz{ddagger}§2

From the {ddagger}Renal-Electrolyte Division, Department of Medicine, and §Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261

Mucolipin-1 (ML1) is a member of the transient receptor potential ion channel superfamily that is thought to function in the biogenesis of lysosomes. Mutations in ML1 result in mucolipidosis type IV, a lysosomal storage disease characterized by the intracellular accumulation of enlarged vacuolar structures containing phospholipids, sphingolipids, and mucopolysaccharides. Little is known about how ML1 trafficking or activity is regulated. Here we have examined the processing and trafficking of ML1 in a variety of cell types. We find that a significant fraction of ML1 undergoes cell type-independent cleavage within the first extracellular loop of the protein during a late step in its biosynthetic delivery. To determine the trafficking route of ML1, we systematically examined the effect of ablating adaptor protein complexes on the localization of this protein. Whereas ML1 trafficking was not apparently affected in fibroblasts from mocha mice that lack functional adaptor protein complex (AP)-3, small interfering RNA-mediated knockdown revealed a requirement for AP-1 in Golgi export of ML1. Knockdown of functional AP-2 had no effect on ML1 localization. Interestingly, cleavage of ML1 was not compromised in AP-1-deficient cells, suggesting that proteolysis occurs in a prelysosomal compartment, possibly the trans-Golgi network. Our results suggest that posttranslational processing of ML1 is more complex than previously described and that this protein is delivered to lysosomes primarily via an AP-1-dependent route that does not involve passage via the cell surface.


Received for publication, October 12, 2005 , and in revised form, February 28, 2006.

* This work was supported by National Institutes of Health Grant R01-DK54407 (to O. A. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by National Institutes of Health T32-DK61296.

2 To whom correspondence should be addressed: Renal-Electrolyte Division University of Pittsburgh, 3550 Terrace St., Pittsburgh, PA 15261. Tel.: 412-383-8891; Fax: 412-383-8956; E-mail: weisz{at}pitt.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
M. T. Miedel, Y. Rbaibi, C. J. Guerriero, G. Colletti, K. M. Weixel, O. A. Weisz, and K. Kiselyov
Membrane traffic and turnover in TRP-ML1-deficient cells: a revised model for mucolipidosis type IV pathogenesis
J. Exp. Med., June 9, 2008; 205(6): 1477 - 1490.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
K. Huang, D. R. Diener, A. Mitchell, G. J. Pazour, G. B. Witman, and J. L. Rosenbaum
Function and dynamics of PKD2 in Chlamydomonas reinhardtii flagella
J. Cell Biol., November 5, 2007; 179(3): 501 - 514.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Zhang and P.-L. Li
Reconstitution and Characterization of a Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-sensitive Ca2+ Release Channel from Liver Lysosomes of Rats
J. Biol. Chem., August 31, 2007; 282(35): 25259 - 25269.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Z. Jin, I. Tietjen, L. Bu, L. Liu-Yesucevitz, S. K. Gaur, C. A. Walsh, and X. Piao
Disease-associated mutations affect GPR56 protein trafficking and cell surface expression
Hum. Mol. Genet., August 15, 2007; 16(16): 1972 - 1985.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Kiselyov, A. Soyombo, and S. Muallem
TRPpathies
J. Physiol., February 1, 2007; 578(3): 641 - 653.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.